Sun Pharma falls 3% as Halol facility gets eight USFDA observations
Updated : December 16, 2019 01:14 PM IST
Shares of Sun Pharma fell 3 percent on Monday after the United States Food and Drug Administration (USFDA) issued a Form 483 for its Halol facility with eight observations.
The stock fell as much as 2.7 percent today to Rs 426.50 per share on the BSE.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more